Composition for inducing islet neogenesis, containing gastrin/CCK receptor ligands and EGF receptor ligands

Details for Australian Patent Application No. 2002243501 (hide)

Owner Waratah Pharmaceuticals, Inc

Inventors Brand, Stephen, J.

Agent Davies Collison Cave

Pub. Number AU-B-2002243501

PCT Pub. Number WO2002/055152

Priority 60/261,638 12.01.01 US

Filing date 11 January 2002

Wipo publication date 24 July 2002

Acceptance publication date 22 November 2007

International Classifications

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-B-2002243501

22 November 2007 Application Accepted

  Published as AU-B-2002243501

20 March 2008 Standard Patent Sealed

5 August 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002243502-Electrostatic spray device

2002243500-WELL TREATMENT FLUID COMPOSITIONS AND METHODS FOR THEIR USE